# Glucose Oxidase as Treatment Against Common Cold

> **NCT01883440** · PHASE2 · COMPLETED · sponsor: **Krister Tano** · enrollment: 90 (actual)

## Conditions studied

- Common Cold

## Interventions

- **DRUG:** Glucose oxidase + glucose
- **DRUG:** Saline+glucose

## Key facts

- **NCT ID:** NCT01883440
- **Lead sponsor:** Krister Tano
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-08
- **Final completion:** 2013-09
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2016-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01883440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01883440, "Glucose Oxidase as Treatment Against Common Cold". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01883440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*